WNT5A and cancer: The secreted WNT5A is primarily known as a noncanonical WNT ligand that contributes less to the initiation of carcinogenesis but strongly supports cancer progression [18] by affecting cell migration, invasion, inflammation, and angiogenesis by diversely binding to the Frizzled (FZD), RYK, and ROR2 receptors [19].